Dutch electronics company Philips has agreed to a massive $1.1 billion settlement to resolve lawsuits linked to its CPAP and ventilator machines consumers were using for sleep apnea. Consumers who ...
Royal Philips said it has reached a $1.1 billion settlement in the U.S. related its Respironics ventilators, and backed its full-year guidance. The Dutch health-technology group said Monday that ...
Medical device company Philips reached a settlement Monday to shell out $1.1 billion to cover hundreds of personal injury lawsuits linked to its respiration and sleep apnea machines. The ...
Millions of CPAP sleep apnea machines made by the medical device maker Philips and a subsidiary were found to have a dangerous problem, triggering consumer lawsuits and a massive recall in 2021.
Dutch electronics company Philips has agreed to a massive $1.1 billion settlement to resolve lawsuits linked to its CPAP and ventilator machines consumers… ...
GSK Plc will sell its remaining stake in Haleon Plc for £1.25 billion ($1.6 billion), completing the drugmaker’s separation from the consumer health company. About 385 million shares will be ...
The Coca-Cola Company (NYSE:KO) recently announced its five-year partnership with Microsoft, aiming to leverage Microsoft's cloud computing and artificial intelligence (AI) services. Coca-Cola ...
Mahindra & Mahindra Ltd., known for its diesel guzzling SUVs, will plow 120 billion rupees ($1.4 billion) into its electric vehicle business over the next three years as the automaker doubles down ...
MONTEVIDEO (Reuters) - Paraguay is advancing talks with energy firms and high-ranking government officials from Argentina and Brazil over a potential $1.5 billion gas pipeline to connect the three ...
Royal Philips said it has reached a $1.1 billion settlement in the U.S. related its Respironics ventilators, and backed its full-year guidance. The Dutch health-technology group said Monday that ...
Royal Philips said that it has reached a $1.1 billion settlement in the U.S. related its Respironics ventilators, and backed its full-year guidance. The Dutch health-technology group said Monday ...